First-in-human phase I trial of two schedules of OSI-930, a novel multikinase inhibitor, incorporating translational proof-of-mechanism studies. (Q37433474)
Jump to navigation
Jump to search
scientific article published on 12 February 2013
Language | Label | Description | Also known as |
---|---|---|---|
English | First-in-human phase I trial of two schedules of OSI-930, a novel multikinase inhibitor, incorporating translational proof-of-mechanism studies. |
scientific article published on 12 February 2013 |
Statements
First-in-human phase I trial of two schedules of OSI-930, a novel multikinase inhibitor, incorporating translational proof-of-mechanism studies (English)
Timothy A Yap
Hendrik-Tobias Arkenau
D Ross Camidge
Suzanne George
Natalie J Serkova
Stephen J Gwyther
Jennifer L Spratlin
Rohit Lal
James Spicer
Nandita M Desouza
Jon Chick
Srinivasu Poondru
Ramesh Boinpally
Richard Gedrich
Katie Brock
Andrew Stephens
S Gail Eckhardt
Stan B Kaye
George Demetri
Michelle Scurr
12 February 2013